Self-sampling to Optimize Anal Lesion Outcomes
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Medical College of Wisconsin
- Study ID
- NCT07192055
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 35 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Self-sampling — BEHAVIORALSelf-sampling instructions will be provided to participants who will insert the swab into the anus to collect cells. Then the participant will put the swab in a vial of transport fluid for assessment at a laboratory.
- Nylon-flocked Swab — OTHERAt the cytology appointment, participants may receive self-sampling or clinician sampling with 1 of 2 kinds of swabs. The nylon-flocked swab is the intervention and will be assessed on patient acceptability and patient and clinician ability to collect an adequate sample.
Study Details
The purpose of this research study is to find ways to increase anal cancer screening among people at increased risk for anal cancer. This study will try to find out if persons will do an intervention (self-sampling of the anal canal) and if it affects cytology and high-resolution anoscopy (HRA) appointment attendance. Secondarily, the study will assess if a person who gets their choice of either self-sampling or healthcare provider sampling affects clinic attendance.
Key Dates
- Start date
- Nov 18, 2025
- Status verified
- Jan 2026
- Primary completion
- Mar 31, 2028
- Completion
- Mar 31, 2029
Study Design
- Enrollment
- 572 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Self-samplingParticipants will self-sample the anal canal with a swab. They will do this at home and at a clinic.
- Active Comparator: Clinician samplingA clinician will collect a sample from the anal canal of the participant with a swab. They will do this at the clinic.
- Experimental: Nylon-flocked swabThis is a swab with nylon-flocked material at the tip.
- Active Comparator: Dacron swabThis is a swab with a Dacron tip.
Primary Outcome Measure
Effect of the self-sampling intervention at cytology [ Time Frame: 1 month ]
Central Contacts
- Alan G Nyitray, PhD4149557701
- Jenna Nitkowski, PhD414-955-2126
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Chicago | Chicago | Illinois | 60637 | |
| The University of Texas M.D. Anderson Cancer Center | Houston | Texas | 77030 | Craig Messick, MD 713-745-1544 |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 |
Find similar trials in Chicago, IL
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Detecting HPV DNA in Anal and Cervical CancersRecruiting · University of Chicago · Chicago, Illinois
- Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal CancerPHASE2 · Recruiting · Dustin Deming · Indianapolis, Indiana
- DESTINY-PANTUMOUR04Recruiting · AstraZeneca · Birmingham, Alabama